Medical Technology

Current search: genetic biotech

@xconomy.com 3 years ago

Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

@xconomy.com 3 years ago

FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures

@xconomy.com 3 years ago

Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases

@xconomy.com 3 years ago

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

@xconomy.com 3 years ago

Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later

@tech.eu 3 years ago

Belgian startup BioStrand raises €2 million to disrupt genetic data analysis

@xconomy.com 4 years ago

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

@xconomy.com 4 years ago

Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business

@xconomy.com 6 years ago

Will New Study Cut Guesswork for Depression Medicine Prescriptions?

@extremetech.com 7 years ago

This genetically engineered ‘living robot’ moves with rat heart cells